This study establishes normative data for the Mandarin Chinese Translation of the Stanford Hypnotic Susceptibility Scale, Form C (SHSS:C-MCT). Fourteen administrators gave the SHSS:C-MCT as well as demographic and meditation questionnaires to 322 participants of Taiwanese nationality. Score distributions, normality, internal consistency, item difficulty, and comparisons with other SHSS:C samples are presented. Scores on the SHSS:C-MCT were compared to both demographic and meditation practice data. The psychometric properties of the SHSS:C-MCT were found to be similar to those of other samples, and the Taiwanese mean score was found to be higher than most other samples, providing support for continued and expanded use of hypnosis in relative treatment applications in Taiwan.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00207144.2012.648062 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Brief interventions for chronic pain: Approaches and evidence.
Curr Opin Psychol
December 2024
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford Pain Relief Innovations Lab, Stanford University School of Medicine, 1070 Arastradero Road, Ste. 200, MC5596, Palo Alto, CA, United States. Electronic address:
Various countries have published national guidance supporting the integration of behavioral approaches into chronic pain treatment. Yet multiple barriers prevent broad patient access. Brief treatment formats may address universal shortcomings of therapists and resources and offer patients expanded access to care through lower costs and treatment burdens.
View Article and Find Full Text PDFHypnosis for Antineoplastic-Related Taste Disturbance in a Patient With Metastatic Breast Cancer.
Psychooncology
December 2024
Department of Psychiatry & Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, USA.
Taste disturbances are prominent side effects of antineoplastic medications and contribute to morbidity and quality-of-life impairment. Few treatment options are available for antineoplastic-related taste disorders. Hypnosis has been found to be effective for a variety of symptoms in the cancer setting, including insomnia, pain, mood disorders and anxiety.
View Article and Find Full Text PDFMasked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial.
JAMA Intern Med
December 2024
Geriatric, Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, California.
Article Synopsis
- Placebo effects are often seen in clinical trials for benzodiazepine receptor agonists, leading to recommendations for discontinuation of these medications in older adults and the use of cognitive behavioral therapy for insomnia (CBTI) instead.
- This study aims to compare the effects of a masked tapering process combined with enhanced CBTI against standard CBTI with an unmasked taper in helping older adults discontinue benzodiazepine receptor agonists.
- The primary outcome measured is the percentage of participants successfully discontinuing their medication after 6 months, with additional assessments of insomnia severity and short-term discontinuation rates.
General Anesthesia Induced by a Combination of Medetomidine/Vatinoxan with Ketamine and Buprenorphine-ER in C57BL/6J Mice (Mus musculus).
J Am Assoc Lab Anim Sci
November 2024
1Department of Comparative Medicine, Stanford University, Stanford, California; and.
Medetomidine/vatinoxan (Zenalpha®) is a novel anesthetic combination used as a sedative and analgesic in dogs. Vatinoxan minimizes adverse cardiopulmonary effects associated with medetomidine administration while preserving sedation and analgesia. In this study, we evaluated the clinical safety and efficacy of 3 dosage combinations of Zenalpha with ketamine and buprenorphine extended release (ER) as compared with xylazine with ketamine and buprenorphine-ER for anesthesia of C57BL/6J mice.
View Article and Find Full Text PDFA General Factor of Hypnotizability Revealed by Confirmatory Factor Analysis.
Int J Clin Exp Hypn
September 2024
Mind-Body Medicine Research Laboratory, Department of Psychology and Neuroscience, Baylor University, Waco, TX, USA.
The objective of this study was to determine the model fit of a standardized hypnotizability measure in a targeted clinical sample. The Stanford Hypnotic Susceptibility Scale, Form C (SHSS:C) was administered to 168 post-menopausal women aged 39 to 75 years. Confirmatory factor analysis was conducted, and comparative fit index (CFI) and root mean square error of approximation (RMSEA) were used to determine goodness of fit.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!